Literature DB >> 16164649

Gender hormones and the progression of experimental polycystic kidney disease.

Kenneth D Stringer1, Radko Komers, Shukri A Osman, Terry T Oyama, Jessie N Lindsley, Sharon Anderson.   

Abstract

BACKGROUND: Male gender is a risk factor for progression of autosomal-dominant polycystic kidney disease (ADPKD), clinically and in the Han:SPRD rat model. Orchiectomy limits progression, but mechanisms of the detrimental effect of androgen, and/or beneficial effects of estrogen, are not known. This protocol tested the hypothesis that male gender (intact androgen status) promotes progression, while female gender (intact estrogen status) is protective; and that these disease-modifying effects are due to changes in expression of known fibrotic mediators.
METHODS: Studies were performed in male and female noncystic control (+/+) and cystic (+/-) rats subjected to orchiectomy, ovariectomy, or sham operation. At 12 weeks of age, renal function was measured. Blood and kidneys were taken for measurement of plasma and renal renin, endothelin (ET-1), endothelial nitric oxide synthase (eNOS), and vascular endothelial growth factor (VEGF), using biochemical, protein expression, and immunohistochemical methods.
RESULTS: Cystic male rats exhibited significantly reduced glomerular filtration (GFR) and effective renal plasma flow (ERPF) rates, with suppression of plasma and renal renin, up-regulation of renal ET-1 and eNOS, and down-regulation of renal VEGF expression. Orchiectomy attenuated the fall in GFR and ERPF, while numerically limiting changes in eNOS and VEGF. Female rats exhibited less cystic growth, with normal renin status, lesser elevation of renal ET-1, and proportionately lesser changes in VEGF and eNOS. Ovariectomy led to higher blood pressure and reduced GFR and ERPF, with a trend toward upregulation of ET-1, and significant down-regulation of VEGF and eNOS.
CONCLUSION: Female gender is protective, but ovariectomy attenuates the protective effect of female gender, in association with changes in renal expression of ET-1, VEGF, and eNOS. The accelerated disease in male rats can be attenuated by orchiectomy and consequent changes in expression of disease mediators.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16164649     DOI: 10.1111/j.1523-1755.2005.00589.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  25 in total

1.  2-Hydroxyestradiol slows progression of experimental polycystic kidney disease.

Authors:  Sharon Anderson; Terry T Oyama; Jessie N Lindsley; William E Schutzer; Douglas R Beard; Vincent H Gattone; Radko Komers
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

Review 2.  ET-1 actions in the kidney: evidence for sex differences.

Authors:  W Kittikulsuth; J C Sullivan; D M Pollock
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 3.  Angiogenesis and autosomal dominant polycystic kidney disease.

Authors:  Jennifer L Huang; Adrian S Woolf; David A Long
Journal:  Pediatr Nephrol       Date:  2012-09-19       Impact factor: 3.714

Review 4.  Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease.

Authors:  Juan Jesus Carrero; Manfred Hecking; Nicholas C Chesnaye; Kitty J Jager
Journal:  Nat Rev Nephrol       Date:  2018-01-22       Impact factor: 28.314

5.  mTORC1/2 and rapamycin in female Han:SPRD rats with polycystic kidney disease.

Authors:  Franck Belibi; Kameswaran Ravichandran; Iram Zafar; Zhibin He; Charles L Edelstein
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-13

6.  Multiomic identification of factors associated with progression to cystic kidney disease in mice with nephron Ift88 disruption.

Authors:  Chunyan Hu; Katherine Beebe; Edgar J Hernandez; Jose M Lazaro-Guevara; Monica P Revelo; Yufeng Huang; J Alan Maschek; James E Cox; Donald E Kohan
Journal:  Am J Physiol Renal Physiol       Date:  2021-12-20

Review 7.  Role of the endothelin system in sexual dimorphism in cardiovascular and renal diseases.

Authors:  Eman Y Gohar; Fernanda R Giachini; David M Pollock; Rita C Tostes
Journal:  Life Sci       Date:  2016-03-03       Impact factor: 5.037

Review 8.  The pathobiology of polycystic kidney disease from a metabolic viewpoint.

Authors:  Luis Fernando Menezes; Gregory G Germino
Journal:  Nat Rev Nephrol       Date:  2019-09-05       Impact factor: 28.314

9.  Gender-Dependent Phenotype in Polycystic Kidney Disease Is Determined by Differential Intracellular Ca2+ Signals.

Authors:  Khaoula Talbi; Inês Cabrita; Rainer Schreiber; Karl Kunzelmann
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

Review 10.  Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors.

Authors:  Annalisa Giandalia; Alfio Edoardo Giuffrida; Guido Gembillo; Domenico Cucinotta; Giovanni Squadrito; Domenico Santoro; Giuseppina T Russo
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.